Use of DDX3X inhibitors for the treatment of pneumovirus infections

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9884812
SERIAL NO

15124748

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a DDX3X inhibitor for use in the treatment of pneumovirus infection in a mammal, wherein the DDX3X inhibitor may be a compound of Formula (I) wherein y, Z, R1, X, L, Ra and Rb are as defined herein. The invention also relates to compounds of Formula (I).

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNIVERSITY OF WARWICKUNIVERSITY HOUSE KIRBY CORNER ROAD COVENTRY WARWICKSHIRE CV4 8UW CV4 8UW

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Easton, Andrew West Midlands, GB 2 2
Gould, Phillip West Midlands, GB 1 0
Marsh, Andrew West Midlands, GB 26 190

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 6, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 6, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00